Total Payments
$117,175
2024 Payments
$276.46
Companies
15
Transactions
161
Medicare Patients
26,398
Medicare Billing
$9.7M
Payment Breakdown by Category
Other$90,910 (77.6%)
Consulting$10,740 (9.2%)
Travel$10,692 (9.1%)
Food & Beverage$4,715 (4.0%)
Education$118.61 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $90,890 | 42 | 77.6% |
| Consulting Fee | $10,740 | 4 | 9.2% |
| Travel and Lodging | $10,692 | 38 | 9.1% |
| Food and Beverage | $4,715 | 73 | 4.0% |
| Education | $118.61 | 3 | 0.1% |
| Honoraria | $20.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $58,133 | 57 | $0 (2023) |
| Celgene Corporation | $53,742 | 64 | $0 (2019) |
| Janssen Biotech, Inc. | $4,624 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $197.95 | 4 | $0 (2024) |
| ABBVIE INC. | $95.10 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $80.96 | 2 | $0 (2018) |
| GENZYME CORPORATION | $73.42 | 2 | $0 (2024) |
| LEO Pharma Inc. | $60.10 | 2 | $0 (2024) |
| Smith+Nephew, Inc. | $33.52 | 2 | $0 (2022) |
| Kerecis Limited | $28.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.46 | 11 | ABBVIE INC. ($95.10) |
| 2023 | $97.31 | 4 | GENZYME CORPORATION ($33.62) |
| 2022 | $7,125 | 9 | Amgen Inc. ($7,075) |
| 2021 | $33,131 | 35 | Amgen Inc. ($33,047) |
| 2020 | $17,990 | 19 | Amgen Inc. ($17,990) |
| 2019 | $20,948 | 24 | Celgene Corporation ($20,823) |
| 2018 | $14,921 | 20 | Celgene Corporation ($10,381) |
| 2017 | $22,687 | 39 | Celgene Corporation ($22,538) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/14/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Biosimilars | ||||||
| 02/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.80 | General |
| Category: Immunology | ||||||
| 12/15/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Immunology | ||||||
| 12/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: Immunology | ||||||
| 10/24/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $28.73 | General |
| Category: Wound Care | ||||||
| 09/28/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Inflammation | ||||||
| 11/10/2022 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Other Advanced Wound Management | ||||||
| 09/27/2022 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/18/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation & Immunology | ||||||
| 05/03/2022 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Inflammation | ||||||
| 05/03/2022 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Inflammation | ||||||
| 04/26/2022 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $1,104.00 | General |
| Category: Inflammation | ||||||
| 04/20/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $96.19 | General |
| Category: Inflammation | ||||||
| 03/04/2022 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Inflammation | ||||||
| 02/11/2022 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Inflammation | ||||||
| 12/13/2021 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,247 | 13,163 | $13.3M | $2.6M |
| 2022 | 34 | 6,427 | 16,503 | $6.9M | $2.8M |
| 2021 | 36 | 6,491 | 13,801 | $5.4M | $2.2M |
| 2020 | 38 | 8,233 | 17,906 | $5.9M | $2.0M |
Total Patients
26,398
Total Services
61,373
Medicare Billing
$9.7M
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q4180 | Revita, per square centimeter | Office | 2023 | 107 | 1,984 | $2.9M | $731,998 | 25.2% |
| Q4229 | Cogenex amniotic membrane, per square centimeter | Office | 2023 | 197 | 3,840 | $3.5M | $658,091 | 19.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 748 | 994 | $2.4M | $480,239 | 19.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 502 | 882 | $1.3M | $266,937 | 20.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 187 | 254 | $582,676 | $117,767 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 833 | 1,012 | $321,816 | $59,208 | 18.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 283 | 323 | $555,237 | $56,919 | 10.3% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 102 | 139 | $199,048 | $40,505 | 20.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 123 | 143 | $222,794 | $23,071 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 241 | $107,486 | $19,628 | 18.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 364 | 443 | $108,535 | $17,671 | 16.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 97 | 107 | $119,091 | $16,976 | 14.3% |
| 15275 | Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 217 | 253 | $145,981 | $15,289 | 10.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 172 | 193 | $73,340 | $12,046 | 16.4% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 76 | 78 | $110,760 | $11,266 | 10.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 167 | 167 | $65,631 | $10,877 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $47,724 | $8,414 | 17.6% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 12 | 12 | $39,336 | $8,086 | 20.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 80 | 93 | $39,060 | $6,586 | 16.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 252 | 1,413 | $35,325 | $6,579 | 18.6% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 40 | 40 | $61,680 | $6,310 | 10.2% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 87 | 104 | $58,864 | $6,028 | 10.2% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 24 | 24 | $43,320 | $4,444 | 10.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 34 | 38 | $23,446 | $4,310 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 93 | 109 | $21,909 | $4,025 | 18.4% |
About Dr. Jeffrey Smith, M.D
Dr. Jeffrey Smith, M.D is a Dermatology healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821119660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Smith, M.D has received a total of $117,175 in payments from pharmaceutical and medical device companies, with $276.46 received in 2024. These payments were reported across 161 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($90,890).
As a Medicare-enrolled provider, Smith has provided services to 26,398 Medicare beneficiaries, totaling 61,373 services with total Medicare billing of $9.7M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location West Columbia, SC
- Active Since 04/02/2007
- Last Updated 01/17/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821119660
Products in Payments
- Otezla (Drug) $108,240
- Tremfya (Drug) $4,487
- DUPIXENT (Biological) $250.77
- STELARA (Biological) $99.99
- RINVOQ (Biological) $95.10
- DUPIXENT (Drug) $80.96
- ADBRY (Biological) $60.10
- TREMFYA (Drug) $37.40
- GRAFIX PL (Medical Supply) $33.52
- Kerecis Omega3 SurgiClose (Device) $28.73
- IDACIO (Biological) $25.67
- LIBTAYO (Biological) $20.60
- CIBINQO (Drug) $16.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.